Literature DB >> 26869472

Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis.

P Gao1, D Wang2, Z Zhao3, Y Cai4, T Li5, H Shi6, W Wu7, W He8, L Yin9, S Huang10, F Zhu1, L Jiao11, X Ji1, A I Qureshi12, F Ling1.   

Abstract

BACKGROUND AND
PURPOSE: On the basis of the high 1-month stroke and/or death (14.7%) rates associated with stent placement in the Stenting versus Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis trial, modifications in patient selection and procedural aspects for intracranial stent placement have been recommended. We performed a multicenter prospective single-arm trial to determine whether such modifications would result in lower rates of periprocedural stroke and/or death.
MATERIALS AND METHODS: The study enrolled patients with recent transient ischemic attack or ischemic stroke (excluding perforator ischemic events) related to high-grade (70%-99% in severity) stenosis of a major intracranial artery. Patients were treated by using angioplasty and self-expanding stents 3 weeks after the index ischemic event at 1 of the 10 high-volume centers in China. An independent neurologist ascertained the occurrence of any stroke and/or death within 1 month after the procedure.
RESULTS: A total of 100 consecutive patients were recruited. The target lesions were located in the middle cerebral artery (M1) (n = 38, 38%), intracranial internal carotid artery (n = 17, 17%), intradural vertebral artery (n = 18, 18%), and basilar artery (n = 27, 27%). The technical success rate of stent deployment with residual stenosis of <50% was 100%. The overall 1-month stroke and/or death rate was 2% (95% confidence interval, 0.2%-7.0%). Two ischemic strokes occurred in the pontine region (perforator distribution) in patients following angioplasty and stent placement for basilar artery stenosis.
CONCLUSIONS: The results of this prospective multicenter study demonstrated that modifications in patient selection and procedural aspects can substantially reduce the 1-month stroke and/or death rate following intracranial stent placement.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2016        PMID: 26869472      PMCID: PMC7960346          DOI: 10.3174/ajnr.A4698

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  The new standard for performance of intracranial angioplasty and stent placement after Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis (SAMMPRIS) Trial.

Authors:  S A Chaudhry; M Watanabe; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-17       Impact factor: 3.825

Review 2.  Assessment of platelet inhibition by point-of-care testing in neuroendovascular procedures.

Authors:  H M Hussein; T Emiru; A L Georgiadis; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

3.  Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial.

Authors:  Colin P Derdeyn; David Fiorella; Michael J Lynn; Zoran Rumboldt; Harry J Cloft; Daniel Gibson; Tanya N Turan; Bethany F Lane; L Scott Janis; Marc I Chimowitz
Journal:  Neurosurgery       Date:  2013-05       Impact factor: 4.654

4.  Rate of postprocedural stroke and death in SAMMPRIS trial-eligible patients treated with intracranial angioplasty and/or stent placement in practice.

Authors:  Farhan Siddiq; Saqib A Chaudhry; Rakesh Khatri; Gustavo J Rodriguez; Ramachandra Tummala; M Fareed K Suri; Adnan I Qureshi
Journal:  Neurosurgery       Date:  2012-07       Impact factor: 4.654

5.  Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study.

Authors:  Yongjun Wang; Xingquan Zhao; Liping Liu; Yannie O Y Soo; Yuehua Pu; Yuesong Pan; Yilong Wang; Xinying Zou; Thomas W H Leung; Yefeng Cai; Qingke Bai; Yiping Wu; Chunxue Wang; Xiaoping Pan; Benyan Luo; Ka Sing Lawrence Wong
Journal:  Stroke       Date:  2014-01-30       Impact factor: 7.914

6.  US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results.

Authors:  David Fiorella; Elad I Levy; Aquilla S Turk; Felipe C Albuquerque; David B Niemann; Beverly Aagaard-Kienitz; Ricardo A Hanel; Henry Woo; Peter A Rasmussen; L Nelson Hopkins; Thomas J Masaryk; Cameron G McDougall
Journal:  Stroke       Date:  2007-02-08       Impact factor: 7.914

7.  Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results.

Authors: 
Journal:  Stroke       Date:  2004-04-22       Impact factor: 7.914

8.  The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis.

Authors:  O O Zaidat; R Klucznik; M J Alexander; J Chaloupka; H Lutsep; S Barnwell; M Mawad; B Lane; M J Lynn; M Chimowitz
Journal:  Neurology       Date:  2008-01-30       Impact factor: 9.910

9.  Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).

Authors:  David Fiorella; Colin P Derdeyn; Michael J Lynn; Stanley L Barnwell; Brian L Hoh; Elad I Levy; Mark R Harrigan; Richard P Klucznik; Cameron G McDougall; G Lee Pride; Osama O Zaidat; Helmi L Lutsep; Michael F Waters; J Maurice Hourihane; Andrei V Alexandrov; David Chiu; Joni M Clark; Mark D Johnson; Michel T Torbey; Zoran Rumboldt; Harry J Cloft; Tanya N Turan; Bethany F Lane; L Scott Janis; Marc I Chimowitz
Journal:  Stroke       Date:  2012-09-13       Impact factor: 7.914

Review 10.  Angioplasty for intracranial artery stenosis.

Authors:  S Cruz-Flores; A L Diamond
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19
View more
  20 in total

1.  Comparison of self-expandable stents and balloon-mounted stents in the treatment of symptomatic intracranial vertebral artery atherosclerotic stenosis.

Authors:  Chunou Tian; Bin Liu; Jianmin Liu; Bo Hong; Puyuan Zhao; Liangliang Yang; Qiuping Li; Zhigang Yang
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Tandem Short-length Multi-stent Construct for Emergent Revascularization of Occlusive Long-segment Left Middle Cerebral Artery In-stent Stenosis.

Authors:  Torin W Karsonovich; Brittany R Bolt; Ajeet Gordhan
Journal:  Cureus       Date:  2020-04-15

3.  A novel technique for stenting in cases of refractory intracranial stenosis.

Authors:  Hugo Cuellar; James Barry; Rimal Hanif
Journal:  Interv Neuroradiol       Date:  2020-01-22       Impact factor: 1.610

4.  Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise.

Authors:  Aysun Erbahceci Salik; Hatem H Selcuk; Hasanagha Zalov; Fatih Kilinc; Musa Cirak; Batuhan Kara
Journal:  Interv Neuroradiol       Date:  2019-04-16       Impact factor: 1.610

5.  Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial.

Authors:  Peng Gao; Tao Wang; Daming Wang; David S Liebeskind; Huaizhang Shi; Tianxiao Li; Zhenwei Zhao; Yiling Cai; Wei Wu; Weiwen He; Jia Yu; Bingjie Zheng; Haibo Wang; Yangfeng Wu; Adam A Dmytriw; Timo Krings; Colin P Derdeyn; Liqun Jiao
Journal:  JAMA       Date:  2022-08-09       Impact factor: 157.335

6.  European Stroke Organisation guidelines on treatment of patients with intracranial atherosclerotic disease.

Authors:  Marios Psychogios; Alex Brehm; Elena López-Cancio; Gian Marco De Marchis; Elena Meseguer; Aristeidis H Katsanos; Christine Kremer; Peter Sporns; Marialuisa Zedde; Adam Kobayashi; Jildaz Caroff; Daniel Bos; Sabrina Lémeret; Avtar Lal; Juan F Arenillas
Journal:  Eur Stroke J       Date:  2022-06-03

Review 7.  Endovascular Therapy for Symptomatic Intracranial Artery Stenosis: a Systematic Review and Network Meta-analysis.

Authors:  Tao Wang; Kun Yang; Xiao Zhang; Jichang Luo; Ran Xu; Xue Wang; Yutong Yang; Xuesong Bai; Yan Ma; Yuxiang Yan; Liqun Jiao
Journal:  Transl Stroke Res       Date:  2022-02-12       Impact factor: 6.800

8.  Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis.

Authors:  Tao Wang; Jichang Luo; Xue Wang; Kun Yang; Vikram Jadhav; Peng Gao; Yan Ma; Na Zhao; Liqun Jiao
Journal:  Cochrane Database Syst Rev       Date:  2020-08-11

9.  Solitaire AB stent-angioplasty for stenoses in perforator rich segments: A single-center experience.

Authors:  Xiangyu Cao; Jun Wang; Chenglin Tian; Zhihua Du; Hui Su; Xinfeng Liu; Bin Lv; Shengyuan Yu; Xing Chen; Ferdinand Hui
Journal:  Interv Neuroradiol       Date:  2020-08-25       Impact factor: 1.610

10.  A Comparison of Safety and Effectiveness Between Wingspan and Neuroform Stents in Patients With Middle Cerebral Artery Stenosis.

Authors:  Kai Zhou; Yuan Cao; Xiao-Hui He; Zhong-Ming Qiu; Shuai Liu; Zi-Li Gong; Jie Shuai; Qing-Wu Yang
Journal:  Front Neurol       Date:  2021-05-20       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.